Breaking News Instant updates and real-time market news.

TIME

Time Inc.

$12.90

-0.9 (-6.52%)

, MDP

Meredith

$57.75

-0.5 (-0.86%)

09:57
08/08/17
08/08
09:57
08/08/17
09:57

Time Inc. plans to cut more costs as revenue falls short

Shares of Time Inc. (TIME) dropped in morning trading after the publisher of Time and People magazine reported lower then expected quarterly revenue and announced plans to cut costs. QUARTERLY RESULTS: Before the market open, Time reported second quarter adjusted earnings per share of 13c, above analysts' estimates of 11c, but quarterly revenue of $694M fell below estimates of $703.5M, reflecting declines in circulation and advertising revenue. Adjusted OIBDA for the quarter was $88M, roughly flat year over year and "met expectations." Circulation revenue fell 12.3% to $207M in the quarter, while advertising revenue declined 12% to $374M. "We believe our advertising revenues were negatively impacted by the public speculation about the ownership of the company and the trailing effect of the disruption from the reorganization of our advertising sales force," the company stated. Time added that although "secular print declines are expected to continue, there is encouraging improvement in print and other advertising for the third quarter of 2017." COST-CUTTING PLANS: Time, which failed to sell itself this year due to disagreements with Meredith Corp (MDP), also announced a cost-cutting plan, and said it was targeting a path to a minimum range of $500M-$600M of adjusted OIBDA in the next three to four years. Rich Battista, Time's chief executive officer, said that "Through this review, we have greater confidence in our path to accelerate the optimization of costs and revenue growth drivers. We have already targeted more than $400M of run-rate cost savings, with the majority of initiatives expected to be implemented over the course of the next 18 months." Battista said Time will use part of these savings to invest in future key growth areas like native and branded content, video, data and targeting. WHAT'S NOTABLE: Time has considered a potential rebranding that could involve changing the company's name in order to position the company as a "more modern entity," The Wall Street Journal said last month, citing several people familiar with the situation. The previous month, Time undertook restructuring measures, cutting about 300 jobs, or 4% of its workforce. The streamlining affected print, corporate, and sales, with over half of the affected employees based in the U.S. At the time, Battista told the Journal that the company was "trying to be as nimble and efficient as possible." Time is also seeking a majority investor for Essence and is looking into the sale of Coastal Living, Sunset, and Golf magazines, and has reportedly hired an investment bank to explore the sale of its Time Inc. U.K. unit, which includes brands such as Horse & Hound, Country Life and Decanter. On its earnings conference call, Battista said Time is getting back to resuming double digit year over year growth in digital advertising. Battista also noted that Time is seeing "strong momentum" in sequential improvement of year over year trends for total advertising revenues in Q3. PRICE ACTION: Time Inc. is down over 6% to $12.95 in early trading. Shares are down 27.5% year-to-date.

TIME

Time Inc.

$12.90

-0.9 (-6.52%)

MDP

Meredith

$57.75

-0.5 (-0.86%)

  • 08

    Aug

TIME Time Inc.
$12.90

-0.9 (-6.52%)

03/20/17
SPHN
03/20/17
UPGRADE
SPHN
Equal Weight
Time Inc. upgraded to Equal Weight from Underweight at Stephens
04/28/17
WELS
04/28/17
DOWNGRADE
WELS
Market Perform
Time Inc. downgraded to Market Perform from Outperform at Wells Fargo
05/02/17
SBSH
05/02/17
UPGRADE
Target $65
SBSH
Buy
Meredith upgraded to Buy from Neutral at Citi
Citi analyst Jason Bazinet upgraded Meredith (MDP) to Buy with the stock down 10% since Time Inc. (TIME) terminated the sale talks. The analyst believes both companies can come back to the negotiating table. He sees $3 of share downside in Meredith if it remains a standalone firm, and $19 of upside in a deal with Time. Bazinet expects Meredith to offer $18 per share for Time, not $20. A deal at that price could push Meredith's shares to $77, the analyst tells investors in a research note. He raised his price target for Meredith to $65 from $58.
06/15/17
MACQ
06/15/17
DOWNGRADE
Target $15
MACQ
Neutral
Time Inc. downgraded to Neutral from Outperform at Macquarie
Macquarie analyst Tim Nollen downgraded Time Inc to Neutral with a $15 price target saying print circulation declines are accelerating and digital growth has not made up the difference.
MDP Meredith
$57.75

-0.5 (-0.86%)

01/26/17
BNCH
01/26/17
DOWNGRADE
Target $64
BNCH
Hold
Meredith downgraded to Hold from Buy at Benchmark
Benchmark analyst Daniel Kurnos downgraded Meredith to Hold from Buy citing the recent run-up in the stock and his belief that a strategic transaction is not imminent. While he still sees a transformative acquisition as the most likely outcome, he sees a challenging outlook for Meredith over the next 2 quarters, said Kurnos, who has a $64 price target on the stock.
01/26/17
SPHN
01/26/17
NO CHANGE
Target $60
SPHN
Equal Weight
Meredith price target raised to $60 from $56 at Stephens
Stephens analyst Kyle Evans raised his price target for Meredith to $60 from $56 after the company posted a "solid" Q2 and reiterated 2017 guidance. The analyst reiterates an Equal Weight on the shares.
06/05/17
BNCH
06/05/17
UPGRADE
Target $65
BNCH
Buy
Meredith upgraded to Buy from Hold at Benchmark
Benchmark analyst Daniel Kurnos upgraded Meredith to Buy with a $65 price target. The analyst sees near-term catalysts in the broadcast space and remains convinced that CEO Steve Lacy will consummate a strategic transaction before the end of his tenure in 18 months.

TODAY'S FREE FLY STORIES

OFIX

Orthofix

$48.51

-0.49 (-1.00%)

10:45
09/20/17
09/20
10:45
09/20/17
10:45
Conference/Events
Orthofix management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

ATVI

Activision Blizzard

$64.31

0.11 (0.17%)

10:45
09/20/17
09/20
10:45
09/20/17
10:45
Periodicals
Activision Blizzard sells esports rights to three additional teams, DJ says »

Activision…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$35.93

0.475 (1.34%)

10:45
09/20/17
09/20
10:45
09/20/17
10:45
Options
Pfizer call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 18

    Oct

  • 31

    Oct

10:45
09/20/17
09/20
10:45
09/20/17
10:45
General news
Euro$ interest rate futures are relatively buoyant »

Euro$ interest rate…

ZLAB

Zai Lab

10:44
09/20/17
09/20
10:44
09/20/17
10:44
Syndicate
Breaking Syndicate news story on Zai Lab »

Zai Lab indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

NKTR

Nektar

$21.75

-0.85 (-3.76%)

10:44
09/20/17
09/20
10:44
09/20/17
10:44
Conference/Events
Nektar management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

MAT

Mattel

$15.05

0.18 (1.21%)

, HAS

Hasbro

$94.99

1.75 (1.88%)

10:44
09/20/17
09/20
10:44
09/20/17
10:44
Hot Stocks
Toymakers in focus after Toys"R"Us files for bankruptcy, Amazon could benefit »

Shares of toymakers,…

MAT

Mattel

$15.05

0.18 (1.21%)

HAS

Hasbro

$94.99

1.75 (1.88%)

JAKK

JAKKS Pacific

$2.83

-0.025 (-0.88%)

KKR

KKR

$19.24

0.15 (0.79%)

VNO

Vornado

$73.34

-0.03 (-0.04%)

AMZN

Amazon.com

$969.86

-4.33 (-0.44%)

WMT

Wal-Mart

$80.29

0.24 (0.30%)

JPM

JPMorgan

$94.12

0.18 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 02

    Oct

  • 10

    Oct

  • 12

    Oct

  • 22

    Oct

  • 23

    Oct

  • 16

    Nov

  • 21

    Nov

  • 20

    Feb

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

MODN

Model N

$13.35

-0.15 (-1.11%)

10:43
09/20/17
09/20
10:43
09/20/17
10:43
Conference/Events
Model N management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 16

    Nov

MMM

3M

$210.50

-3.06 (-1.43%)

10:43
09/20/17
09/20
10:43
09/20/17
10:43
Hot Stocks
Analyst says sell 3M amid slowdown in autos, electronics »

JPMorgan downgraded 3M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ODP

Office Depot

$4.35

-0.07 (-1.58%)

, ADP

ADP

$107.48

0.93 (0.87%)

10:42
09/20/17
09/20
10:42
09/20/17
10:42
Hot Stocks
Office Depot says David Bleisch joins as Chief Legal Officer »

Office Depot (ODP)…

ODP

Office Depot

$4.35

-0.07 (-1.58%)

ADP

ADP

$107.48

0.93 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZLAB

Zai Lab

10:40
09/20/17
09/20
10:40
09/20/17
10:40
Syndicate
Zai Lab indicated to open at $23, IPO priced at $18 »

Zai Lab (ZLAB) priced 8M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

10:40
09/20/17
09/20
10:40
09/20/17
10:40
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

APC

Anadarko

$44.64

0.88 (2.01%)

10:35
09/20/17
09/20
10:35
09/20/17
10:35
Options
Anadarko put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

JCOM

j2 Global

$73.37

-1.52 (-2.03%)

10:35
09/20/17
09/20
10:35
09/20/17
10:35
Conference/Events
j2 Global management to meet with JMP Securities »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 28

    Sep

PFE

Pfizer

$35.85

0.4 (1.13%)

, JNJ

Johnson & Johnson

$133.60

-1.62 (-1.20%)

10:34
09/20/17
09/20
10:34
09/20/17
10:34
Hot Stocks
Pfizer takes J&J to court as analysts shake up pharma ratings »

Morgan Stanley analyst…

PFE

Pfizer

$35.85

0.4 (1.13%)

JNJ

Johnson & Johnson

$133.60

-1.62 (-1.20%)

LLY

Eli Lilly

$82.24

0.505 (0.62%)

NVS

Novartis

$86.11

0.26 (0.30%)

ABBV

AbbVie

$86.90

0.53 (0.61%)

BMY

Bristol-Myers

$63.08

0.1532 (0.24%)

AGN

Allergan

$211.28

-3.725 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 22

    Sep

  • 22

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 17

    Oct

  • 18

    Oct

  • 26

    Oct

  • 31

    Oct

  • 09

    Nov

  • 05

    Mar

  • 17

    May

10:31
09/20/17
09/20
10:31
09/20/17
10:31
General news
Crude inventories for week of September 15 »

Crude oil inventories…

PYPL

PayPal

$63.83

0.91 (1.45%)

10:30
09/20/17
09/20
10:30
09/20/17
10:30
Recommendations
PayPal analyst commentary  »

PayPal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 22

    Oct

  • 29

    Nov

10:30
09/20/17
09/20
10:30
09/20/17
10:30
General news
The 1.7% U.S. August existing home sales drop »

The 1.7% U.S. August…

AAXN

Axon

$22.07

-0.33 (-1.47%)

10:29
09/20/17
09/20
10:29
09/20/17
10:29
Periodicals
Studies about Taser's safety were overstated, Reuters reports »

Claims about early…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$317.93

-0.25 (-0.08%)

, CBAY

CymaBay

10:29
09/20/17
09/20
10:29
09/20/17
10:29
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

BIIB

Biogen

$317.93

-0.25 (-0.08%)

CBAY

CymaBay

EVH

Evolent Health

$16.18

0.5299 (3.39%)

EPZM

Epizyme

$19.25

1.4 (7.84%)

INTU

Intuit

$145.34

1.54 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 03

    Oct

  • 22

    Oct

  • 25

    Oct

JNJ

Johnson & Johnson

$133.80

-1.42 (-1.05%)

, UAL

United Continental

$58.01

0.47 (0.82%)

10:29
09/20/17
09/20
10:29
09/20/17
10:29
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

JNJ

Johnson & Johnson

$133.80

-1.42 (-1.05%)

UAL

United Continental

$58.01

0.47 (0.82%)

IR

Ingersoll-Rand

$88.85

-1.61 (-1.78%)

LB

L Brands

$37.40

-1.83 (-4.66%)

YAHOY

Yahoo Japan

$9.02

-0.03 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 27

    Sep

  • 02

    Oct

  • 17

    Oct

PFE

Pfizer

$35.91

0.455 (1.28%)

, PGR

Progressive

$47.57

-0.065 (-0.14%)

10:29
09/20/17
09/20
10:29
09/20/17
10:29
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

PFE

Pfizer

$35.91

0.455 (1.28%)

PGR

Progressive

$47.57

-0.065 (-0.14%)

AAL

American Airlines

$44.38

-0.93 (-2.05%)

LUV

Southwest

$53.77

0.23 (0.43%)

POST

Post Holdings

$86.68

0.32 (0.37%)

NDSN

Nordson

$114.62

0.12 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 02

    Oct

  • 18

    Oct

  • 31

    Oct

CELC

Celcuity

10:29
09/20/17
09/20
10:29
09/20/17
10:29
Syndicate
Celcuity opens at $12.35, IPO priced at $9.50 per share »

Celcuity (CELC) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

WDC

Western Digital

$89.92

0.74 (0.83%)

, TOSBF

Toshiba, also use TOSYY

$2.89

0.01 (0.35%)

10:28
09/20/17
09/20
10:28
09/20/17
10:28
Recommendations
Western Digital, Toshiba, also use TOSYY analyst commentary  »

Western Digital…

WDC

Western Digital

$89.92

0.74 (0.83%)

TOSBF

Toshiba, also use TOSYY

$2.89

0.01 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$81.07

-0.12 (-0.15%)

10:25
09/20/17
09/20
10:25
09/20/17
10:25
Conference/Events
Medtronic has conference call hosted by Leerink »

Leerink to hold a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.